Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | 1₹2.5 CrAccepted-AOC | ₹2.5 Cr Quoted ₹278.25 | 1 | Accepted-AOC L1 bidder |
| 2 | 1₹0.88Rejected-AOC JOURIAN BHATTIAN PATIALA | PATIALA | PATIALA | PUNJAB | ₹0.88 | 1 | Rejected-AOC L1 bidder |
| 3 | 1₹235.10Rejected-AOC | ₹235.10 | 1 | Rejected-AOC L3 bidder |
| 4 | 1₹254.91Rejected-AOC CHANDIGARH CHANDIGARH 160047 | CHANDIGARH | CHANDIGARH | 160047 | ₹254.91 | 1 | Rejected-AOC L2 bidder |
| 5 | 2₹268.28Rejected-Finance | ₹268.28 | 2 | Rejected-Finance L2 bidder in Human Insulin |
Tender Value
Refer Docs
EMD Value
₹2 L
Closing Date
18 May 2021, 11:00 amClosed
Mission Director
NHM, Sector 38, Chandigarh
Supply of Medicines under Covid
2021_DHFW_65340_13
Tender/Proc-Cov/2021/NHM-25
Open Tender
Consumables (Hospital / Lab)
Item Wise
7 days
NHM, Sector 38, Chandigarh
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹2 L
29 Jul 2022
15 May 2021
18 May 2021
15 May 2021
18 May 2021
15 May 2021
Medical Equipment
Supply of Tablet Paracetamol 650 mg
Supply of Inj. Enoxaparin 0.6 mg
Supply of Inj. Enoxaparin 0.6 mg
Supply of Tablet Asthalin 4mg
Inj. 25%/75% (100IU) in 3ml Cartridge (Contains insulin neutral with Insulin Isophane) or Mixtard 70/30 IU ml Human Biphasic Isophane Insulin
BATRA PHARMACEUTICAL DISTRIBUTORS
CAPTAB BIOTEC UNIT II
umang chhabra
Singla Pharmaceuticals
CAPTAB BIOTEC UNIT II
SANGAM MEDICAL STORE
stage.html
html • 0.05 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .